Nymox Pharmaceutical Corp (NASDAQ:NYMX)

Data as of 12:56pm ET
 +0.0101 / +2.52%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Nymox Pharmaceutical Corp. is a biopharmaceutical company, which specializes in the research and development of products for the aging population. Currently, it markets NicAlertTM and TobacAlertTM, tests that use urine or saliva to detect use of tobacco products. The company develops NX-1207, a novel treatment for benign prostatic hyperplasia, which is in Phase 3 clinical trials. It also has pipeline drug candidates aimed at the causes of Alzheimer's disease and new treatments of bacterial infections in humans. Nymox Pharmaceutical was founded by Paul Averback on May 30, 1995 and is headquartered in St.-Laurent, Canada.

Contact Information

Nymox Pharmaceutical Corp.
9900, boulevard Cavendish
Saint-Laurent Quebec H4M 2V2
P:(800) 936-9669
Investor Relations:



Other institutional3.54%
Mutual fund holders2.17%
Individual stakeholders--

Top Executives

Paul AverbackChairman, President & Chief Executive Officer
André MonetteChief Financial Officer
Jack GemmellChief Information Officer
Brian DoyleDirector-Business Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.